research use only

Muscone NF-κB inhibitor

Name: Muscone
SKU: S3871
Availability: InStock
Rating: 5 (4 reviews)

Cat.No.S3871

Muscone (3-Methylcyclopentadecanone, Methylexaltone), a flavouring ingredient, is an organic compound that is the primary contributor to the odor of musk and also a potent anti-inflammatory agent. This compound significantly downregulats the levels of LPS-induced inflammatory cytokines and inhibits NF-κB and NLRP3 inflammasome activation in BMDMs. It remarkably decreases the levels of inflammatory cytokines (IL-1β, TNF-α and IL-6).

Chemical Structure

Molecular Weight: 238.41

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability Specificity

Quality Control

Batch: Purity: 98.59%

98.59

Related Targets	Antioxidant HDAC ROS IκB/IKK Nrf2 AP-1 MALT NOD
Related Products	BAY 11-7082 (BAY 11-7821) JSH-23 QNZ (EVP4593) SC75741 Caffeic Acid Phenethyl Ester DHA (Dihydroartemisinin) Andrographolide Evodiamine Withaferin A (WFA) CBL0137 Magnolol Omaveloxolone (RTA-408) Hyperoside Neferine SN50 Stachydrine Curcumenol NF-κB-IN-1 Sodium 4-Aminosalicylate Chondroitin sulfate Engeletin Benfotiamine Ethyl caffeate Dauricine Sodium Aescinate 4-Hydroxychalcone Sodium salicylate 4'-Methoxyresveratrol TCEP Hydrochloride Cornuside

Chemical Information, Storage & Stability

Molecular Weight	238.41	Formula	C₁₆H₃₀O	Storage (From the date of receipt)	2 years -20°C liquid
CAS No.	541-91-3	Download SDF		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (419.44 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	0.850mg/ml (3.57mM)	Taking the 1 mL working solution as an example, add 50 μL of 17 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC₅₀/Ki	NF-κB ^[4] NLRP3 inflammasome ^[4] IL-1β ^[4] TNF-α ^[4] IL-6 ^[4]
In vitro	Muscone induces CYP1A2 and CYP3A4 expression in liver cells in vitro and in vivo^[1]. This compound protects PC12 cells against glutamate-induced apoptosis by attenuating ROS generation and Ca2+ influx, via NR1 and CaMKII-depended ASK-1/JNK/p38 signaling pathways^[2]. It could promote bone marrow-derived mesenchymal stem cells (BMSCs) migration and proliferation^[3].
In vivo	Muscone exhibits liver toxicity in Kunming mice at concentrations higher than 50 mg/kg^[1]. It exerts potent neuroprotective activities on cerebral ischemia^[2]. This compound could accelerate the migration of BMSCs to the injured area in vivo^[3].
References	[1] https://pubmed.ncbi.nlm.nih.gov/28110334/ [2] https://pubmed.ncbi.nlm.nih.gov/24636892/ [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019657/ [4] https://pubmed.ncbi.nlm.nih.gov/30662666/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT05559307	Recruiting	Ischemic Stroke Acute	Ying Gao\|Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital\|Dongzhimen Hospital Beijing	August 16 2022	Phase 4

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):